ExCellThera announces oral presentation of new data on UM171-expanded cell therapy at the ASH Annual Meeting
November 04, 2022 09:30 ET
|
ExCellThera
MONTREAL, Nov. 04, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a world leader in blood stem cell expansion and rejuvenation, announced today that an abstract related to ExCellThera’s...
Mendus AB: Mendus presenterar flera abstracts på ASH 2022, inklusive en muntlig presentation av uppdaterade AML-överlevnadsresultat från fas 2-studien ADVANCE II
November 03, 2022 09:10 ET
|
Mendus AB
Mendus AB (“Mendus” publ; IMMU.ST, eller “Bolaget”), ett bioläkemedelsföretag fokuserat på immunterapier som adresserar tumöråterfall, kan idag meddela att uppdaterade resultat från bolagets pågående...
Mendus AB: Mendus to present multiple abstracts at ASH 2022 including an oral presentation of updated AML survival results from the Phase 2 ADVANCE II trial
November 03, 2022 09:10 ET
|
Mendus AB
Mendus AB (“Mendus” publ; IMMU.ST, or “the Company”), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that updated results from the Company’s...
Scip & Savor for a Cure Fundraiser Benefits the International Myeloma Foundation (IMF) and Family Reach
October 27, 2022 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced the details of the recent fundraising celebration hosted by Fatima Scipione and her...
The AcCELLerate Forum to Focus on Creating a Sustainable Ecosystem of Cell and Gene Therapy
October 24, 2022 12:00 ET
|
ASTCT
MINNEAPOLIS, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The AcCELLerate Forum, a joint partnership between the American Society for Transplantation and Cellular Therapy (ASTCT™), the Center for International...
Global Oncology Nutrition Market Report 2022: A $2.13 Billion Market in 2026 Featuring B. Braun Melsungen, Danone India, Abbott Laboratories, Nestle, Victus
October 06, 2022 06:13 ET
|
Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global oncology nutrition market is...
The Annual Miracles for Myeloma 5K Hybrid Run/Walk Celebrates 10th Anniversary
September 29, 2022 08:45 ET
|
International Myeloma Foundation
CLARK, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Annual Miracles for Myeloma 5K Hybrid Run/Walk will be celebrating its tenth anniversary this year. For the past nine years, this annual event has...
CURE Media Group Opens Nominations for Multiple Myeloma Heroes® Award Program
August 04, 2022 15:54 ET
|
CURE Media Group
The Recognition Will Honor Individuals Who Have Made a Significant Difference in the Lives of Those Affected by Multiple Myeloma CRANBURY, N.J., Aug. 04, 2022 (GLOBE NEWSWIRE) -- CURE Media...
Dr. Owhofasa Agbedia to Receive the 2021 ASH-CIBMTR-ASTCT Career Development Award
June 22, 2022 11:00 ET
|
American Society for Transplantation and Cellular Therapy (ASTCT)
CHICAGO, June 22, 2022 (GLOBE NEWSWIRE) -- American Society for Transplantation and Cellular Therapy (ASTCT) is pleased to announce that Owhofasa Agbedia, MD, MPH, has been selected by the American...
ExCellThera announces submission of Drug Master File for UM171
June 17, 2022 08:05 ET
|
ExCellThera
MONTRÉAL, June 17, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions to expand and...